Search

Supplemental material, sj-pdf-4-cep-10.1177_03331024231187132 for Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study by Kent A. Jamtøy, Wenche M. Thorstensen, Lars J. Stovner, Annika Rosén, Stine Maarbjerg, Daniel Bratbak, Melanie R. Simpson and Erling Tronvik in Cephalalgia

Supplemental material, sj-pdf-3-cep-10.1177_03331024231187132 for Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study by Kent A. Jamtøy, Wenche M. Thorstensen, Lars J. Stovner, Annika Rosén, Stine Maarbjerg, Daniel Bratbak, Melanie R. Simpson and Erling Tronvik in Cephalalgia

Supplemental material, sj-pdf-5-cep-10.1177_03331024231187132 for Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study by Kent A. Jamtøy, Wenche M. Thorstensen, Lars J. Stovner, Annika Rosén, Stine Maarbjerg, Daniel Bratbak, Melanie R. Simpson and Erling Tronvik in Cephalalgia

Supplemental material, sj-pdf-2-cep-10.1177_03331024231187132 for Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study by Kent A. Jamtøy, Wenche M. Thorstensen, Lars J. Stovner, Annika Rosén, Stine Maarbjerg, Daniel Bratbak, Melanie R. Simpson and Erling Tronvik in Cephalalgia

Supplemental material, sj-pdf-1-cep-10.1177_03331024231187132 for Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study by Kent A. Jamtøy, Wenche M. Thorstensen, Lars J. Stovner, Annika Rosén, Stine Maarbjerg, Daniel Bratbak, Melanie R. Simpson and Erling Tronvik in Cephalalgia

Objective - To explore whether plaque and gingival bleeding are more frequently experienced by adolescents with juvenile idiopathic arthritis (JIA) compared to matched controls without JIA; explore whether surface- and site-specific periodontal outcomes vary between the two groups; and for participants with JIA, investigate associations between disease-specific features and periodontal outcomes. Material and methods - In this comparative cross-sectional study, selected surfaces, and sites of index teeth in 10–16-year-olds with JIA and matched controls were examined by modified versions of Simplified Oral Hygiene Index (OHI-S) and Gingival Bleeding Index (GBI). Mixed-effects logistic regressions, reporting odds ratios (OR) with 95% confidence interval (CI), were applied. Intra-class correlation coefficients (ICCs) were calculated to quantify the degree of dependency of measures within the same individual. Results - 144 and 159 adolescents with JIA were evaluated according to OHI-S and GBI; corresponding numbers of controls were 154 and 161. Plaque and gingival bleeding were more frequent in individuals with JIA than controls. Adjusted analyses showed association between JIA status and OHI-S > 0 (OR = 2.33, 95% CI: 1.47 − 3.67, ICC = 0.45) and GBI > 0 (OR = 1.54, 95% CI: 1.10 − 2.16, ICC = 0.41 and 0.30). Surface-specific distribution of plaque varied among the two groups. Conclusions - Our results highlight the importance of increased awareness of oral health care in patients with JIA and that surface- and site-specific differences in periodontal outcomes exist between individuals with JIA and controls. Few JIA disease-specific variables associated with plaque or gingival bleeding.

Additional file 10. Table S1. Disease-specific features and dental caries in relation to the outcome variable Early Childhood Oral Health Impact Scale (ECOHIS) total score and Child Oral Impacts on Daily Performance (Child-OIDP) simple count (SC) score. Unadjusted and adjusted negative binominal regressions.

Additional file 8. Table S1. Discriminant validity of the Early Childhood Oral Health Impact Scale (ECOHIS) and Child Oral Impacts on Daily Performances (Child-OIDP) according to the global measures and group affiliation.

Additional file 2. Calibration.

Additional file 4: Supplemental file S4. Additional adjustments in the regression analyses.

Additional file 2: Supplemental file S2. Oral health assessments.

Additional file 3: Supplemental file S3. Dietary and supplemental vitamin D intake.

Additional file 5. Table S1. Categories for Child Oral Impacts on Daily Performances (Child-OIDP) (12–16 years) and questions regarding satisfaction with oral health (global measures), as originally coded and as re-coded for analyses.

Additional file 7. Table S1. Categories for JIA-specific background variables, as originally coded and re-coded for analyses.

Additional file 6. Description of JIA-specific background variables.

Additional file 1: Supplemental file S1. Calibration.

Background Temporomandibular disorders (TMD) are common and affect approximately 10% of the adult population. TMD is usually associated with headache, pain in the masticatory muscles and/or the temporomandibular joint, clicking or crepitations during mandibular movement as well as painful and/or reduced mouth opening. This study aimed to investigate the level TMD-patients use social insurance benefits before and after their first time of diagnosis or first surgical event, compared to the general population. Furthermore, the aim was to investigate the differences in the use of social insurance benefits between surgically and non-surgically treated TMD-patients that were diagnosed in a hospital setting. Methods All Swedish citizens aged 23–59 diagnosed with TMD in a hospital setting and/or surgically treated for the condition during 1998–2016 were identified via the Swedish National Board of Health and Welfare. A non-exposed comparison cohort was collected via the Total Population Registry. Outcome and sociodemographic data were collected via Statistics Sweden. Main outcome was annual net days on sick leave and disability pension five years before (-T5) and five years after (T5) diagnosis and/or surgical treatment (T0). Regression analysis was conducted with generalized estimated equations. Results The study included 219 255 individuals (73% female) – 19 934 in the exposed cohort and 199 321 in the comparison cohort. The exposed group was classified into three subgroups: non-surgical, surgically treated once, and surgically treated twice or more. The mean annual net days of sick leave and disability pension combined during the ten-year follow-up was 61 days in the non-surgical group, 76 days in the surgically treated once group, and 104 days in the surgically treated twice or more subgroup. The corresponding number for the non-exposed comparison cohort was 32 days. Conclusion Patients diagnosed with TMD in a hospital setting are 2–3 times more dependent on the use of social benefits than the general population. The reliance on sick leave and disability pension is seen as early as five years before diagnosis, and the reliance remains after surgical treatment. The reliance is stronger in patients with several surgical interventions. These findings indicate that patients diagnosed with TMD constitute a patient group with a high burden of health issues causing long-term dependence on social security benefits. publishedVersion